| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Product | Enzyme |
| Phosphoenolpyruvate + erythrose 4-phosphate | DHAP Synthase => |
| 7P-2-dehydro-3-deoxy-d-arabino-heptonate | 3-dehydroquinate synthase => |
| Dehydroquinate | 3-dehydroquinate dehydratase => |
| Dehydroshikimate | Shikimate 5-dehydrogenase => |
| Skikimate | Shikimate kinase => |
| Shikimate-3-P | EPSP synthase => |
| 5-0-(1-carboxyvinyl)-3-phosphoshikimate | Chorismate synthase => |
| Chorismate | |
Chorismate can now go to any of 5 different pathways; were concerned with the tryptophan pathway:
| Product | Enzyme |
| Chorismate | 2-deoxyisochorismate synthase => |
| 2-amino-2-deoxychorismate | Anthranilate synthase => |
| Anthranilate | Anthranylate-phosphoribosyl transferase => |
| N-(5phosphoribosyl) anthranilate | N-(5phosphoribosyl) anthranilate isomerase => |
| Enol-1-0 carboxyphenylamino-1-deoxyribulose phosphate | indole-3-glycerolphosphate synthase => |
| Indole-3-glycerolphosphate | Tryptophan synthase (a subunit) => |
| Indole | Tryptophan synthase (b subunit) => |
| Tryptophan | Tryptophan decarboxylase => |
| Tryptamine | |
Tryptophan is decarboxylated via an enzyme called tryptophan decarboxylase to form tryptamine. This is the last major step in the pathway that is significantly inhibited by a self-feedback downregulation mechanism, meaning that if too much of a particular substance is in the cells the enzyme will stop converting tryptophan to tryptamine. Here is a list of some inhibitors of tryptophan decarboxylase (copied from a paper at the lycaeum; unknown URL:)
Inhibition of Tryptophan Decarboxylase |
||
| Type of inhibition | Inhibitor | % Inhibition |
| Competitive Inhibitors: | N,N-dimethyltryptamine | 65 |
| Indole-3-acetic acid | 60 | |
| (Unknown Mechanism:) | Tryptamine | 62 |
| 5-Hydroxytryptamine | 45 | |
| Indole-3-acetaldehyde | 50 | |
| Non-Inhibitors: | 5-Methoxy-N,N-dimethyltryptamine | (0) |
| 5-Methoxytryptamine | (0) | |
| Indole-3-pyruvic acid | (0) | |
The pathway for the conversion of tryptamine to psilocybin and psilocin is still unclear, but it is proposed that there are many different steps, since the phosphorylated intermediates baeocystin and norbaeocystin are produced, in addition to psilocybin, which is most likely produced via one phosphorylase enzyme from psilocin. The experiments by Gartz et al. regarding an addition of tryptamine hcl to the substrate showed an increase in psilocin levels compared to psilocybin which suggests the downregulation of a phosphorylase enzyme at this step, and also provides some possible insight to the evolution of psilocybin in mushrooms.
PRIMARY PATHWAYS:
Both of the starting materials of the Shikimic Acid Pathway, phosphoenolpyruvate and erythrose 4-phosphate, are ultimately a product of glucose. Glucose is phosphorylated by ATP, which loses a phosphoryl group to glucose to become ADP:

The Glucose 6-P is then used on two different pathways, glycolysis and the Pentose
Phosphate Pathway to produce our two starting materials.
Phosphoenolpyruvate is produced as a byproduct of glycolysis:

....and Erythrose-4-P is produced as a biproduct of the Pentose Phosphate Pathway:

by micro
References: